Financial Daily from THE HINDU group of publications
Thursday, Nov 27, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Announcements
Marketing - New Products & Services
Industry & Economy - Health


Aventis launches osteoporosis programme

Our Bureau

Mumbai , Nov. 26

AVENTIS Pharma Ltd has launched `Wishbone,' a comprehensive healthcare management programme for women diagnosed with osteoporosis.

The programme will be initially available across the six metros of Mumbai, Chennai, Hyderabad, Bangalore, Kolkata and Delhi. The programme has features like diagnosis, treatment and overall patient care, including on-call counsellors, physiotherapists and nutritionist.

At the core of the programme is the Aventis drug, Actonel, proven to achieve both rapid vertebral fracture reduction and sustained vertebral and hip fracture reduction, according to Dr Sandeep Bhattacharya, director of the company.

Osteoporosis patients can enrol with Wishbone for a registration fee of Rs 1,000, followed by a monthly payment of Rs 2,000. Included in these costs are services like adjuvant therapy, marker tests, insurance cover for fractures, educational material and peer group support programme.

Article E-Mail :: Comment :: Syndication

Stories in this Section
IDL to pay Rs 15 lakh to blast victims' kin


Aventis launches osteoporosis programme
More Aquila cruiser bikes on the way — May come with higher price tag
Onus on banks to see cos hedge forex loans
ICSI looking at new avenues for members
Welspun-Gujarat to hike Dahej unit capacity
LG Elec sets up compressor plant
Coffee Day ties up with GSK to distribute new brand
Education in animation tech — Dr Reddy's LABS ties up with Color Chips
Escorts tractor unit pegs Rs 175 cr profit in 2 years
For capacity addition, capital goods import — More mid-size cos tap bank funds


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line